TAXUS® LIBERTÉ®
Report
- Report Number
- 2134265-2013-00148
- Event Type
- Injury
- Date Received
- January 22, 2013
- Date of Event
- November 26, 2012
- Report Date
- December 24, 2012
- Manufacturer
- BOSTON SCIENTIFIC - GALWAY
- Product Code
- NIQ
- PMA / PMN Number
- P060008
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(6). DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MFR: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).
(B)(4). SAME CASE AS MDR ID: 2134265-2013-00147. IT WAS REPORTED THAT SUBSEQUENT TO A STENTING TREATMENT PROCEDURE THE PATIENT EXPERIENCED STENT THROMBOSIS AND A MYOCARDIAL INFARCTION. IN (B)(6) 2009 THE PATIENT UNDERWENT A CARDIAC CATHETERIZATION PROCEDURE REVEALING ONE TARGET LESION. A 3.50X32MM AND 3.50X16MM TAXUS STENTS WERE IMPLANTED IN THE PROXIMAL RIGHT CORONARY ARTERY (RCA). JUST OVER THREE YEARS LATER THE PATIENT RETURNED AND A ST-ELEVATED MYOCARDIAL INFARCTION WAS DIAGNOSED (PEAK CK TOTAL= 485, ULN=269 IU/L; CK-MB=61.2, ULN= 5.0 NG/ML; PEAK TROPONIN= 15.65, ULN= 0.20 NG/ML). CORONARY ANGIOGRAPHY REVEALED A THROMBUS AND 100% OCCLUSION OF THE PROXIMAL RCA STENTS THAT WERE DEPLOYED IN (B)(6) 2009. A 3.50X40MM APEX MONORAIL BALLOON CATHETER WAS ADVANCED AND ANGIOPLASTY WAS PERFORMED RESULTING IN 0% RESIDUAL STENOSIS. THE EVENT WAS CONSIDERED RESOLVED TWO DAYS LATER WITHOUT RESIDUAL EFFECTS AND THE PATIENT WAS DISCHARGED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 29438 | TAXUS® LIBERTÉ® | CORONARY DRUG-ELUTING STENT | NIQ | BOSTON SCIENTIFIC - GALWAY | H7493893616350 | 12558918 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 51 YR | Required Intervention |